Sign In
Buy ATHA
$6.61
+0 (+0%)
At Close: Apr 14, 2026
Athena Gold Successfully Completes Excelsior Springs Monetization
07:00am, Friday, 22'nd Aug 2025
EXCELSIOR SPRINGS FULLY FUNDED FOR 2025 DRILLING PROGRAM WHITE ROCK, BC / ACCESS Newswire / August 22, 2025 / Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) ("Athena" or the "Company") is pleased to
Athira (ATHA) Q2 Loss Narrows 74%
05:21pm, Thursday, 07'th Aug 2025
Athira Pharma (ATHA -2.38%), a biopharmaceutical company developing drugs for neurodegenerative diseases, released its second quarter results on August 7, 2025. The update centered on its cost contain
ATHA Discovers Athabasca-Style High-Grade Mineralization at RIB East
07:00am, Monday, 21'st Jul 2025
HIGHLIGHTS First three drill holes completed at RIB East Discovery successfully targeted stacked gravity, EM and structural anomalies (Figure 2), and intersected uranium mineralization, as part of the
Athena Gold Completes Till Survey At Laird Lake Project In Ontario's Red Lake Gold Camp
07:00am, Monday, 14'th Jul 2025
WHITE ROCK, BC / ACCESS Newswire / July 14, 2025 / Athena Gold Corporation (CSE:ATHA)(OTCQB:AHNRF) ("Athena Gold" or the "Company") is pleased to announce the successful completion of its comprehensiv
HIGHLIGHTS Completes first two drill holes of its 2025 Angilak Exploration Program comprising ~10,000m of diamond drilling. KU Discovery Target: The maiden drill hole, KU-DD-001 successfully targeted
ATHA Completes Ground Geophysics and Commences 2025 Angilak Diamond Drill Exploration Program
07:30am, Wednesday, 04'th Jun 2025
HIGHLIGHTS The 2025 Angilak Exploration Program will comprise ~10,000 m of diamond drilling with two objectives: Lac 50 Deposit - expansion of the footprint of uranium mineralization. Stepping out alo
Athira Pharma to Present Data from First-in-Human Phase 1 Clinical Trial of ATH-1105 at the 4th Annual ALS Drug Development Summit
11:00am, Tuesday, 13'th May 2025
Data from Phase 1 clinical trial of ATH-1105 in healthy volunteers showed a favorable safety and tolerability profile; dose proportional pharmacokinetics and CNS penetration support continued clinical
Athira Pharma Reports First Quarter 2025 Financial Results and Pipeline and Business Updates
04:05pm, Friday, 09'th May 2025
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS); full healthy volunteer data expected in 2H25
Athena Gold Closes Oversubscribed Flow-Through Financing
04:45pm, Monday, 28'th Apr 2025
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VACAVILLE, CALIFORNIA
ATHA Energy Announces Closing of Financing for Aggregate Gross Proceeds of $10,000,000
08:35am, Tuesday, 22'nd Apr 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / April 22, 2025 / ATHA Energy Corp. (TSXV:SASK)(FRA:X5
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
04:05pm, Thursday, 27'th Feb 2025
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)
ATHA Energy expands uranium potential at Angilak
09:43am, Wednesday, 15'th Jan 2025
ATHA Energy Corp (TSX-V:SASK, OTCQB:SASKF) revealed that a survey at its Angilak uranium project in Nunavut has expanded the known depth of uranium mineralization at the Lac 50 Deposit to over one ki
Seattle biotech firm Athira Pharma will pay $4M to settle allegations related to research misconduct
05:15pm, Tuesday, 07'th Jan 2025
Seattle-area biotech company Athira Pharma agreed to pay $4.
BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and sl
ATHA Energy identifies high-grade uranium mineralization in new outcrops at Angilak
09:40am, Thursday, 05'th Dec 2024
ATHA Energy Corp (TSX-V:SASK, OTCQB:SASKF) said it has uncovered numerous outcrops hosting high-grade uranium mineralization at Angilak in Nunavut. The surficial mapping program, centered around the L
